medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2018, Number 3

<< Back

Acta Ortop Mex 2018; 32 (3)

Syndrome of vertebral destruction: understanding to practice

Cahueque-Lemus MA, Cobar-Bustamante AE, Bregni-Duraés MC, Jiménez-Ávila JM

Language: Spanish
References: 19
Page: 182-187
PDF size: 316.62 Kb.


ABSTRACT

The term «vertebral destruction syndrome» comprises pathologies causing structural changes in the spine, mainly in the vertebral body, producing mechanical deformity and neurological involvement. The pathologies found in this definition may be infectious, metabolic or tumoral. Vertebral osteomyelitis is a disease that occurs mainly in adults > 50 years; we speak of spondylodiscitis when the condition affects the disc and vertebral body. The most important organism in vertebral osteomyelitis is Staphylococcus aureus, seen in over 50% of cases. Tumors of the spine can start from local or adjacent spinal injuries or distant ones, and spread through the blood or lymphatic system. Metastases account for about 97% of all tumors of the spine. Primary tumors that most commonly spread to the spine are lung, prostate, breast and kidney. Metabolic bone diseases are a group of disorders that occur as a result of changes in the calcium metabolism. The spine contains large amounts of metabolically active cancellous bone, which must withstand axial loads during stance. Osteoporosis is a metabolic disease that most commonly affects the spine; it is characterized by low bone mass. The diagnosis of these entities is important for the treatment and prognosis of the patient. The term «vertebral destruction syndrome» proposes a notarized scheme aimed at improving the patient’s prognosis and his/her prompt treatment.


REFERENCES

  1. DeSanto J, Ross JS. Spine infection/inflammation. Radiol Clin North Am. 2011; 49(1): 105-27.

  2. Mylona E, Samarkos M, Kakalou E, Fanourgiakis P, Skoutelis A. Pyogenic vertebral osteomyelitis a systematic review of clinical characteristics. Semin Arthritis Rheum. 2009; 39(1): 10-7.

  3. Mesfin A, Buchowski JM, Gokaslan ZL, Bird JE. Management of metastatic cervical spine tumors. J Am Acad Orthop Surg. 2015; 23(1): 38-46.

  4. Mizumoto M, Harada H, Asakura H, Hashimoto T, Furutani K, Hashii H, et al. Radiotherapy for patients with metastases to the spinal column: a review of 603 patients at Shizuoka Cancer Center Hospital. Int J Radiat Oncol Biol Phys. 2011; 79(1): 208-13.

  5. Switlyk MD, Kongsgaard U, Skjeldal S, Hald JK, Hole KH, Knutstad K, et al. Prognostic factors in patients with symptomatic spinal metastases and normal neurological function. Clin Oncol (R Coll Radiol). 2015; 27(4): 213-21.

  6. Sehn JK, Gilula LA. Percutaneous needle biopsy in diagnosis and identification of causative organisms in cases of suspected vertebral osteomyelitis. Eur J Radiol. 2012; 81(5): 940-6.

  7. Zapałowicz K, Radek M. Percutaneous balloon kyphoplasty in the treatment of painful vertebral compression fractures: effect on local kyphosis and one-year outcomes in pain and disability. Neurol Neurochir Pol. 2015; 49(1): 11-5.

  8. Alpizar-Aguirre A, Elías-Escobedo A, Rosales-Olivares LM, Miramontes-Martínez V, Reyes-Sánchez A. Vertebral destruction syndrome. Diagnostic evaluation systems. Cir Cir. 2012; 76(3): 205-11.

  9. Turunc T, Demiroglu YZ, Uncu H, Colakoglu S, Arslan H. A comparative analysis of tuberculous, brucellar and pyogenic spontaneous spondylodiscitis patients. J Infect. 2007; 55(2): 158-63.

  10. Dunbar JA, Sandoe JA, Rao AS, Crimmins DW, Baig W, Rankine JJ, et al. The MRI appearances of early vertebral osteomyelitis and discitis. Clin Radiol. 2010; 65(12): 974-81.

  11. Carragee EJ. The clinical use of magnetic resonance imaging in pyogenic vertebral osteomyelitis. Spine (Phila Pa 1976). 1997; 22(7): 780-5.

  12. Alexiou E, Georgoulias P, Valotassiou V, Georgiou E, Fezoulidis I, Vlychou M. Multifocal septic osteomyelitis mimicking skeletal metastatic disease in a patient with prostate cancer. Hell J Nucl Med. 2015; 18(1): 77-8.

  13. Carragee EJ, Kim D, van der Vlugt T, Vittum D. The clinical use of erythrocyte sedimentation rate in pyogenic vertebral osteomyelitis. Spine (Phila Pa 1976). 1997; 22(18): 2089-93.

  14. Gupta A, Kowalski TJ, Osmon DR, Enzler M, Steckelberg JM, Huddleston PM, et al. Long-term outcome of pyogenic vertebral osteomyelitis: a cohort study of 260 patients. Open Forum Infect Dis. 2014; 3(1): ofu107.

  15. Lozano-Calderon SA, Colman MW, Raskin KA, Hornicek FJ, Gebhardt M. Use of bisphosphonates in orthopedic surgery: pearls and pitfalls. Orthop Clin North Am. 2014; 45(3): 403-16.

  16. Kordecki K, Lewszuk A, Puławska-Stalmach M, Michalak P, Łukasiewicz A, Sackiewicz I, et al. Vertebroplasty of cervical vertebra. Pol J Radiol. 2015; 80: 51-6.

  17. Roedel B, Clarençon F, Touraine S, Cormier E, Molet-Benhamou L, Le Jean L, et al. Has the percutaneous vertebroplasty a role to prevent progression or local recurrence in spinal metastases of breast cancer? J Neuroradiol. 2015; 42(4): 222-8.

  18. Araujo JL, Veiga JC, Figueiredo EG, Barboza VR, Daniel JW, Panagopoulos AT. Management of metastatic spinal column neoplasms--an update. Rev Col Bras Cir. 2013; 40(6): 508-14.

  19. Gasbarrini A, Boriani S, Capanna R, Casadei R, Di Martino A, Silvia Spinelli M, et al. Management of the patient with metastasis to the vertebrae: recommendations of the Italian Orthopaedic Surgery bone metastasis group. Expert Rev Anticancer Ther. 2014; 14(10): 1127-34




2020     |     www.medigraphic.com